Pharmafile Logo
Pharmafocus logo
Advanced Search

AIDS

Showing 15 posts of 41 posts found.

hiv_on_macrophage

Viiv Healthcare’s cabotegravir effective in HIV prevention in women

November 9, 2020
Sales and Marketing AIDS, HIV

Viiv Healthcare’s cabotegravir is more effective in preventing HIV in women than the oral standard of care, according to an …

News
mozzie

Florida approve plan to release 750 million genetically modified mosquitoes to stop the spread of disease

June 19, 2020
Medical Communications AIDS, HIV, mosquitoes

Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread …

News
48610088067_59be70df49_b

Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women

March 10, 2020
Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin

Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …

News
20181130-niaid-hiv-test

Uganda finalising clinical trials on new injectable HIV drug

March 9, 2020
Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …

News
mental-3436232_1280

Lack of mental health treatment available for HIV patients in the UK

March 6, 2020
Medical Communications AIDS, HIV, HIV AIDS, HIV treatment, HIV/AIDS

A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …

News
syringe-and-hypodermic-needles

Rapid testing to help combat worst UK outbreak of HIV in 30 years

February 18, 2020
Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS

New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …

News
assorted-condoms

Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds

February 5, 2020
Research and Development AIDS, HIV, STDs, STIs, UK, sexual health

The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …

News

HIV infections fall by 73% in bi and gay British men

January 16, 2020
Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland

Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …

News
180921-drugs-pills-bottle-faeture-image

Labour and Lib Dems make election pledge for wider access to HIV drug

December 2, 2019
Sales and Marketing AIDS, Conservatives, HIV. HIV Drugs, Labour Party, Liberal Democrats, lib dems

The Labour Party and the Liberal Democrats have both pledged to roll out access to pre-exposure prophylaxis (PrEP) therapy for …

News
gilead-sciences

Gilead challenges Government over patents on preventative HIV drug Truvada

August 22, 2019
Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents

Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …

News
1920px-hiv-budding-color

GSK’s two drug HIV regimen effective when administered every two months

August 22, 2019
Research and Development AIDS, GSK, HIV, ViiV Healthcare, viral supression

GSK’s long-acting, two-drug HIV regimen was as effective in supressing patient’s viral loads when administered every two months (eight weeks), …

News
1920px-hiv-budding-color

Scientists use duoCAR-T therapy to fight HIV

August 9, 2019
Medical Communications AIDS, CAR-T therapy, HIV, health, immunotherapy, pharma

Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …

News
gilead-sciences

Gilead’s PrEP drug Descovy should be approved for men and transgender women but not cis-gender women, FDA advisory panel says

August 8, 2019
Research and Development AIDS, Gilead, HIV, PrEP, descovy, pharma

Independent experts on a panel advising the FDA have voted in favour of Gilead’s new PrEP drug Descovy in men …

News
1920px-hiv-budding-color

MSD trials long lasting PrEP implant for preventing HIV

July 23, 2019
Research and Development AIDS, HIV, MSD, PrEP, pharma

MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said. The US firm has tested …

News
1920px-hiv-budding-color

ViiV Healthcare’s two drug HIV therapy beats Gilead’s three drug treatment in Phase 3 trial

July 10, 2019
Research and Development AIDS, Dovato, GSK, Gilead, HIV, ViiV, pharma

Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024